Biotechnology R&D expenditures in Spain declined 3.3% in 2012 to €1,455 million ($1,865 million), following a 4.4% decline in 2011, to account for 11% of total Spanish R&D spending. Biotech R&D spending by government, business and higher education declined 3.7%, 2.7% 3.8% to make up 40%, 36% and 24% of total internal biotech R&D expenditures, […]
Japanese expenditures on R&D declined 0.3% in fiscal 2012 (ending March 31, 2013) to ¥17.32 trillion ($20.8 billion). This marks the first decline in two years. The ratio of R&D spending to GDP remained 3.67%. Spending by business declined 0.8% to make up 70% of all R&D expenditures. R&D spending by universities and colleges grew […]
As part of the US Centers for Medicare & Medicaid Services’ (CMS) final 2014 Medicare physician fee schedule (PFS) released in November, the CMS has announced a new process for reviewing payment amounts for tests that are part of the Clinical Laboratory Fee Schedule (CLFS). The CLFS sets the price paid by Medicare for clinical […]
According to a report by EuroStemCell, the Kyoto University Institute for Integrated Cell-Material Sciences and Elsevier based on an analysis of publications in the Scopus database, stem cell research is growing rapidly. Stem cell research publications totaled 21,193 in 2012 to make up 1% of global scientific publications. Between 2008 and 2012, the number of […]
The FDA has announced that it plans to revise the language of two draft food safety rules, which were announced in January as part of the Food Safety Modernization Act’s Produce Safety Rule and Preventive Controls for Human Food (see IBO 1/31/13). The rules proposed standards for the produce industry and safety requirements for food […]
New York, NY 10/22/13; New York, NY 11/27/13; New York, NY 12/6/13; New York, NY 12/27/13—The District Court for the Southern District of New York has ruled in two suits brought by life science consumables firm Enzo Biochem. In October, the court granted Amersham’s motion for summary judgment, denying Enzo’s claims of fraudulent inducement, breach […]
Reinach, Switzerland 12/30/13—Matthias Altendorf will become CEO of measurement instrumentation and services firm Endress+Hauser effective January 1, 2014 (see IBO 5/15/13). He previously served as managing director of the company’s Center of Competence for level and pressure measurement engineering in Maulburg, Germany. He replaces Klaus Endress, who will join the Supervisory Board after 19 years […]
Port Washington, NY 12/23/13; Danbury, CT 12/23/13—Filtration and separation firm Pall has agreed to acquire ATMI Life Sciences from ATMI, a provider of specialty semiconductor materials, for $185 million. ATMI Life Sciences provides single-use process systems and consumables for the pharmaceutical and biopharmaceutical industries. “This acquisition immediately strengthens our offering and broadens our already extensive […]
New York, NY 12/19/13; San Francisco, CA 12/19/13—Certara, a provider of model-based drug development and data analytics software and consulting services, has been sold by Vector Capital to Arsenal Capital Partners. Financial details were not provided. Certara’s solutions cover the discovery, preclinical and clinical stages of drug development. “Technology-driven informatics models will not only result […]
Santa Clara, CA 12/17/13—Agilent Technologies has named Fred Strohmeier senior vice president, Agilent, and president of the Life Sciences and Diagnostics Group (LDG). He replaces Lars Holmkvist who left the company for personal reasons. Most recently, Mr. Strohmeier served as vice president and general manager of Life Science Products and Solutions. “He is a highly […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
